Elmar Kraus
Stock Analyst at DZ BANK AG
(4.04)
# 1,688
Out of 4,581 analysts
149
Total ratings
68.9%
Success rate
10.3%
Average return
Main Sectors:
Stocks Rated by Elmar Kraus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Maintained: Hold | n/a | $1,996.00 | - | 10 | Jul 29, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | n/a | $13,146.00 | - | 14 | Jul 28, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | n/a | $770.20 | - | 3 | Jul 24, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Hold | n/a | $129.86 | - | 9 | Jul 22, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | n/a | $330.56 | - | 13 | May 7, 2026 | |
| PFE Pfizer | Maintained: Buy | n/a | $25.27 | - | 9 | May 6, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Buy | n/a | $364.50 | - | 12 | Feb 2, 2026 | |
| ABBV AbbVie | Downgraded: Hold | $188 → $237 | $265.43 | -10.71% | 4 | Nov 4, 2025 | |
| EPA: SAN Sanofi | Maintained: Buy | n/a | $79.90 | - | 9 | Oct 24, 2025 | |
| AMS: PHIA Koninklijke Philips N.V. | Maintained: Hold | n/a | $22.58 | n/a | 7 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $72 → $108 | $133.78 | n/a | 7 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $331 → $343 | $396.25 | n/a | 5 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,068 → $1,065 | $696.89 | n/a | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $820 → $800 | $1,221.03 | n/a | 6 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 → $50 | $63.51 | n/a | 3 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $148 | $131.05 | n/a | 2 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $181 → $176 | $267.90 | n/a | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $242 → $236 | $214.69 | n/a | 4 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $24.02 | n/a | 1 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $37.21 | n/a | 20 | Apr 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $52.84 | n/a | 1 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $41.44 | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $90 → $92 | $87.56 | n/a | 2 | May 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $41 | $25.75 | n/a | 1 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $51.37 | n/a | 1 | May 3, 2018 |
GSK plc
Jul 29, 2026
Maintained: Hold
Price Target: n/a
Current: $1,996.00
Upside: -
AstraZeneca PLC
Jul 28, 2026
Maintained: Buy
Price Target: n/a
Current: $13,146.00
Upside: -
argenx SE
Jul 24, 2026
Maintained: Buy
Price Target: n/a
Current: $770.20
Upside: -
Novartis AG
Jul 22, 2026
Maintained: Hold
Price Target: n/a
Current: $129.86
Upside: -
Novo Nordisk A/S
May 7, 2026
Maintained: Hold
Price Target: n/a
Current: $330.56
Upside: -
Pfizer
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $25.27
Upside: -
Roche Holding AG
Feb 2, 2026
Maintained: Buy
Price Target: n/a
Current: $364.50
Upside: -
AbbVie
Nov 4, 2025
Downgraded: Hold
Price Target: $188 → $237
Current: $265.43
Upside: -10.71%
Sanofi
Oct 24, 2025
Maintained: Buy
Price Target: n/a
Current: $79.90
Upside: -
Koninklijke Philips N.V.
Jul 29, 2025
Maintained: Hold
Price Target: n/a
Current: $22.58
Upside: n/a
Feb 13, 2025
Upgraded: Buy
Price Target: $72 → $108
Current: $133.78
Upside: n/a
May 7, 2024
Maintained: Buy
Price Target: $331 → $343
Current: $396.25
Upside: n/a
May 6, 2024
Maintained: Buy
Price Target: $1,068 → $1,065
Current: $696.89
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $820 → $800
Current: $1,221.03
Upside: n/a
Apr 30, 2024
Maintained: Buy
Price Target: $61 → $50
Current: $63.51
Upside: n/a
Apr 29, 2024
Maintained: Buy
Price Target: $125 → $148
Current: $131.05
Upside: n/a
Apr 18, 2024
Maintained: Buy
Price Target: $181 → $176
Current: $267.90
Upside: n/a
Feb 15, 2024
Maintained: Hold
Price Target: $242 → $236
Current: $214.69
Upside: n/a
Nov 2, 2023
Maintained: Buy
Price Target: $39
Current: $24.02
Upside: n/a
Apr 20, 2022
Maintained: Hold
Price Target: n/a
Current: $37.21
Upside: n/a
Feb 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $52.84
Upside: n/a
Aug 24, 2021
Maintained: Buy
Price Target: n/a
Current: $41.44
Upside: n/a
May 14, 2020
Downgraded: Hold
Price Target: $90 → $92
Current: $87.56
Upside: n/a
Mar 24, 2020
Upgraded: Buy
Price Target: $41
Current: $25.75
Upside: n/a
May 3, 2018
Maintained: Sell
Price Target: n/a
Current: $51.37
Upside: n/a